Metabolic Solutions Development Co. LLC

Metabolic Solutions Development Co. LLC

Metabolic Solutions Development Co. LLC

Overview
Date Founded

2011

Headquarters

161 EAST MICHIGAN AVENUE 4TH FLOOR Kalamazoo MI 49007

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Pharmaceuticals
Holding Companies
Biotechnology

Company Description

Metabolic Solutions Development Co. LLC operates as a drug discovery and development company. It develops novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes. The company was founded by Jerry Colca and Rolf Kletzien in 2006 and is headquartered in Kalamazoo, MI.

Contact Data
Trying to get in touch with decision makers at Metabolic Solutions Development Co. LLC? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder

Co-Founder

Chief Executive Officer

Chief Medical Officer

Vice President-Development

Paths to Metabolic Solutions Development Co. LLC
Potential Connections via
Relationship Science
You
Metabolic Solutions Development Co. LLC
Recent Transactions
Details Hidden

Metabolic Solutions Development Co. LLC raised money in a private placement transaction

Details Hidden

Metabolic Solutions Development Co. LLC raised money in a private placement transaction

Details Hidden

Metabolic Solutions Development Co. LLC raised money in a private placement transaction

Investors
Details Hidden

Charter Private Capital Management, Inc. focuses on investments in early-stage life science and technology companies that are based in Western Michigan. The firm seeks to transfer and commercialize new technologies arising from the state's universities and research institutions. Although, they focus on healthcare and life sciences investments, a portion of their investments are allocated to Michigan industries including advanced manufacturing, alternative energy and homeland security

Details Hidden

Hopen Life Sciences focuses on investments in a portfolio of early- to mid-stage life science companies in the areas of diagnostics, therapeutics, pharmaceuticals, medical devices, and enabling technologies. They seek to identify healthcare companies with innovations that meet an unmet market need s and to assist companies in accelerating their products' time to market. The firm is not bound by specific disease indications, market size or geographic region. Investments have ranged from $150,000 to $5 million, although Hopen Therapeutics Group prefers to make investments in the range of $200,000 to $2 million. Hopen Life Sciences makes seed investments (with proof-of-concept) through Series B investments. They prefer to lead investment rounds or syndicates.

Details Hidden

Co-Founder at Metabolic Solutions Development Co. LLC

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Metabolic Solutions Development Co. LLC. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Metabolic Solutions Development Co. LLC's profile does not indicate a business or promotional relationship of any kind between RelSci and Metabolic Solutions Development Co. LLC.